中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
22期
7-8
,共2页
陶娟%李涛%薛国平%余俊文
陶娟%李濤%薛國平%餘俊文
도연%리도%설국평%여준문
猪苓多糖%维持性血液透析%乙肝疫苗%免疫接种
豬苓多糖%維持性血液透析%乙肝疫苗%免疫接種
저령다당%유지성혈액투석%을간역묘%면역접충
Polyporus polysaccharide%Maintenance hemodialysis%Hepatitis B vaccination%Immunization
目的探讨猪苓多糖能否作为降低维持性血液透析(MHD)患者乙肝感染率的有效药物。方法82例MHD患者分为实验组和对照组,实验组行猪苓多糖联合乙肝疫苗接种,对照组单用乙肝疫苗接种,观察接种后1个月、12个月时两组患者血清HBsAb的阳性率及接种后6个月、12个月时两组患者的乙肝感染率。结果接种后实验组患者血清HBsAb的阳性率明显较对照组高、乙肝感染率明显较对照组低。结论猪苓多糖可以作为降低MHD患者乙肝感染率的有效药物。
目的探討豬苓多糖能否作為降低維持性血液透析(MHD)患者乙肝感染率的有效藥物。方法82例MHD患者分為實驗組和對照組,實驗組行豬苓多糖聯閤乙肝疫苗接種,對照組單用乙肝疫苗接種,觀察接種後1箇月、12箇月時兩組患者血清HBsAb的暘性率及接種後6箇月、12箇月時兩組患者的乙肝感染率。結果接種後實驗組患者血清HBsAb的暘性率明顯較對照組高、乙肝感染率明顯較對照組低。結論豬苓多糖可以作為降低MHD患者乙肝感染率的有效藥物。
목적탐토저령다당능부작위강저유지성혈액투석(MHD)환자을간감염솔적유효약물。방법82례MHD환자분위실험조화대조조,실험조행저령다당연합을간역묘접충,대조조단용을간역묘접충,관찰접충후1개월、12개월시량조환자혈청HBsAb적양성솔급접충후6개월、12개월시량조환자적을간감염솔。결과접충후실험조환자혈청HBsAb적양성솔명현교대조조고、을간감염솔명현교대조조저。결론저령다당가이작위강저MHD환자을간감염솔적유효약물。
Objective To explore thewhether polyporus polysaccharide can be used asan effective drug to reduce infection rate of hepatitisB forof maintena ncehemodialysis(MHD) patientswithHepatitisB. Methods 82 MHD patients were divided into two groups, theexperimental group(inoculated withpolyporus polysaccharide andcombined hHepatitis B vaccination) and control group(inoculated with onlyHhepatitis B vaccination alone).Serum HBsAbwere detectedpositive rate after1and12 months of inoculationinfor patients ofboth groupswere detectedon1,12 months after inoculation, and Hepatitis B infection rate were detectedobserved onafter 6and, 12 months after inoculation. Results HBsAb positive rate ofin experimental group was significantly higherthan the control group, and hHepatitis B infection rateof experimental group was lower.than the control group.Conclusion Polyporus polysaccharide can be used as aneffective drugs to reducehe patitis Binfection for MHD patients with Hepatitis B infection